Reprogramming of pancreatic islet cells for regeneration and rejuvenation.

The pancreatic ß cell, which produces insulin, is a terminally differentiated cell type that divides rarely. Consequently, the regenerative ability of ß cells is limited and irreversible diabetes occurs after severe loss of ß-cell function. In view of such poor regenerative capacity, considerable research efforts have been made to promote the expansion of functional insulin-producing cells as a regenerative therapy for diabetes. Here, we discuss recent findings regarding the robust expansion of functional mature islet cells both in vivo and ex vivo through MYCL-mediated reprogramming. We also describe the potential prospects for the application of reprogramming technologies to regenerative therapy and rejuvenation of islet cells.